As per a peer-reviewed Lancet study, the efficacy of covaxin is 77.8%
The interim results of a Phase 3 study of Covaxin, an Indian vaccine developed by Bharat Biotech and the Indian ...
The interim results of a Phase 3 study of Covaxin, an Indian vaccine developed by Bharat Biotech and the Indian ...
According to Reuters, a technical committee of the World Health Organization (WHO) will assess the India-made Covaxin shot for approval ...
The World Health Organization requested further information from India's Bharat Biotech on Monday to examine the company's request for an ...
Bharat Biotech announced on Friday that it has terminated its Memorandum of Understanding with Precisa Medicamentos and Envixia Pharmaceuticals LLC ...
Bharat Biotech spoke on Friday that it has agreed to supply the Centre with approximately 500 million doses of its ...
After studying a WHO document, Hyderabad-based vaccine producer Bharat Biotech will have its pre-submission meet with the World Health Organization ...
Bharat Biotech on thursday, 20th May has said that they have ramped up the production of Covaxin. Chiron Behring, a ...
The Union Minister Nitin Gadkari suggested that more pharma companies needs to be given permission for the production of Covid-19 ...
The senior NITI Aayog member, VK Paul announced on Tuesday that the phase II/III clinical trials will begin in 10-12 ...
Bharat Biotech's indigenous Corona vaccine 'Kovaxine' has shown better immune response in the first phase of clinical trials. No side ...
© 2024 The Edge Media All Rights Reserved.
© 2024 The Edge Media All Rights Reserved.